Cargando…

CARDIOVASCULAR PATIENT OUTCOMES AND COMPLICATIONS AFTER SARS-COV-2 INFECTION

Detalles Bibliográficos
Autores principales:	Khodaverdi, M., Visaria, Aayush, Hong, Stephanie, Makwana, Priyal, Wen, Sijin, Kimble, Wesley, Chapman, Scott, Sokos, George G., Patel, Brijesh D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2022
Materias:	Spotlight on Special Topics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972427/ http://dx.doi.org/10.1016/S0735-1097(22)03104-7

Ejemplares similares

COVID-19 RELATED OUTCOMES IN PATIENTS WITH PREEXISTING CARDIOVASCULAR DISEASES, WITH OR WITHOUT CANCER
por: Patel, Brijesh D., et al.
Publicado: (2022)

HEMATOLOGICAL ABNORMALITIES IN CARDIOVASCULAR AND CARDIO-ONCOLOGY PATIENTS ARE ASSOCIATED WITH WORSE COVID-19 OUTCOMES
por: Visaria, Aayush, et al.
Publicado: (2022)

TIME SINCE LAST CHEMOTHERAPY AND COVID-19 OUTCOMES IN CARDIO-ONCOLOGY INPATIENTS
por: Visaria, Aayush, et al.
Publicado: (2022)

HEALTH DISPARITIES INVOLVING HOSPITALIZATIONS AMONG COVID-19 VACCINATED CARDIOVASCULAR DISEASE PATIENTS INFECTED BY SARS-COV-2
por: Khodaverdi, M., et al.
Publicado: (2022)

Outcomes of Patients with Active Cancers and Pre-Existing Cardiovascular Diseases Infected with SARS-CoV-2
por: Patel, Brijesh, et al.
Publicado: (2023)

Outcomes of patients with active cancers and pre-existing cardiovascular diseases infected with SARS-CoV-2
por: Patel, Brijesh, et al.
Publicado: (2023)

CARDIOVASCULAR COMPLICATIONS IN HOSPITALIZED PATIENTS WITH SARS-COV-2 INFECTION AND HISTORY OF CANCER
por: Siddiqi, Hasan, et al.
Publicado: (2021)

SARS-COV-2 PLATELET FUNCTION & THROMBOTIC COMPLICATIONS: EFFECTS OF ASPIRIN THERAPY IN COVID-19
por: Bhandari, Rohan, et al.
Publicado: (2021)

PREVALENCE AND OUTCOMES OF CARDIOVASCULAR COMPLICATIONS AMONGST COVID-19 PATIENTS
por: Aedma, Surya Kiran, et al.
Publicado: (2021)

CARDIOVASCULAR COMORBIDITIES PREDISPOSE TO CARDIOVASCULAR COMPLICATIONS IN HOSPITALIZED PATIENTS WITH COVID-19 INFECTION
por: Razipour, Shadi, et al.
Publicado: (2022)

FOLLOW-UP OF HOSPITALIZED COVID-19 SURVIVORS: ASSESSMENT OF SHORT AND LONG-TERM CARDIOVASCULAR SEQUELAE AFTER SARS-COV-2 INFECTION
por: Birtolo, Lucia Ilaria, et al.
Publicado: (2022)

OUTCOMES OF LIFE-THREATENING CARDIOVASCULAR COMPLICATIONS AND CORONAVIRUS DISEASE 19- A COHORT STUDY
por: Khorsandi, Michael, et al.
Publicado: (2021)

CARDIOVASCULAR COMPLICATIONS OF COVID-19 AND IT'S TRUE MORTALITY IN A LARGE METROPOLITAN HEALTH SYSTEM
por: Dulas, Marissa, et al.
Publicado: (2022)

SARS-COV-2 AND STROKE IN A LARGE HEALTHCARE SYSTEM
por: Katapadi, Aashish, et al.
Publicado: (2021)

RISK OF CARDIOVASCULAR COMPLICATIONS IN ETHNIC MINORITIES INFECTED WITH COVID-19 - EXPERIENCE IN A MID-SIZED MIDWESTERN CITY
por: Desai, Viral, et al.
Publicado: (2021)

STATIN USE AND OUTCOMES IN HOSPITALIZED PATIENTS WITH SARS-COV-2 INFECTION
por: Siddiqi, Hasan, et al.
Publicado: (2021)

LUNG INJURY AND FUNCTIONAL CAPACITY POST-SARS-COV-2 INFECTION
por: Bandera, Francesco, et al.
Publicado: (2021)

MACHINE-LEARNING CHARACTERIZATION OF SUBTLE HEMODYNAMIC INSTABILITY DIFFERENTIATES COVID-19 VERSUS SEASONAL INFLUENZA IN HOSPITALIZED PATIENTS
por: Yanamala, Naveena, et al.
Publicado: (2021)

SARS-COV-2 VIRAL LOAD AND CARDIAC INJURY ARE INDEPENDENT AND INCREMENTAL PREDICTORS OF IN-HOSPITAL MORTALITY
por: Chehab, Omar, et al.
Publicado: (2021)

CARDIORESPIRATORY INDICES IN RELATION TO MARKERS OF PSYCHOPATHOLOGY AND NEUROCOGNITIVE FUNCTION IN POST SARS-COV-2 INFECTED SUBJECTS
por: Fragoulis, Christos, et al.
Publicado: (2022)

THE CLINICAL COURSE OF PATIENTS WITH A HISTORY OF ACUTE PERICARDITIS FOLLOWING VACCINATION AGAINST SARS-COV2
por: Wasserstrum, Yishay, et al.
Publicado: (2022)

CARDIOVASCULAR AND MORTALITY OUTCOMES IN ONCOLOGY PATIENTS HOSPITALIZED WITH COVID-19
por: Kwan, Jennifer, et al.
Publicado: (2021)

RELATIONSHIPS BETWEEN MYOCARDIAL INJURY, INDEX HOSPITALIZATION CHARACTERISTICS, AND LONGER-TERM OUTCOMES IN SARS-COV-2 INFECTION
por: Weber, Brittany, et al.
Publicado: (2021)

APABETALONE (RVX-208) REDUCES ACE2 PROTEIN ABUNDANCE AND PREVENTS SARS-COV-2 SPIKE PROTEIN BINDING TO HUMAN LUNG CELLS, A MOA THAT COULD ATTENUATE VIRAL ENTRY
por: Fu, Li, et al.
Publicado: (2021)

SPORTS CLEARANCE FOLLOWING SARS-COV-2 INFECTION IN CHILDREN: DOES NONINVASIVE TESTING PREDICT ABNORMAL CARDIAC MRI?
por: Tejtel, Sara Kristen Sexson, et al.
Publicado: (2021)

ROLE OF ANTIBODIES, INFLAMMATORY MARKERS, AND ECHOCARDIOGRAPHIC FINDINGS IN POST-ACUTE CARDIOPULMONARY SYMPTOMS AFTER SARS-COV-2 INFECTION
por: Durstenfeld, Matthew, et al.
Publicado: (2022)

CARDIOVASCULAR AND MORTALITY OUTCOMES OF HOSPITALIZED COVID-19 PATIENTS STRATIFIED BY RACE AND ETHNICITY
por: Kwan, Jennifer, et al.
Publicado: (2021)

PREDICTING COVID-19 INPATIENT MORTALITY AND MORBIDITY BY USING CARDIOVASCULAR RISK SCORES
por: Ahmed, Eyad, et al.
Publicado: (2021)

THE OCCURRENCE AND MORTALITY ASSOCIATED WITH MYOCARDIAL ISCHEMIA AND INJURY IN SARS-COV-2 INDUCED SEPSIS: A RETROSPECTIVE MULTICENTER OBSERVATIONAL ANALYSIS
por: Solsi, Anup, et al.
Publicado: (2022)

TROPONIN-I PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS AND RISK OF MORTALITY IN COVID-19 PATIENTS
por: Patel, Chirag, et al.
Publicado: (2021)

FEASIBILITY AND SAFETY OF A CARDIAC MAGNETIC RESONANCE IMAGING PROTOCOL INCLUDING PHARMACOLOGIC STRESS IN CHILDREN AFTER SARS-COV-2 INFECTION
por: Britt, Jolie, et al.
Publicado: (2021)

THE IMPACT OF THE COVID-19 PANDEMIC ON ACCESS TO CARDIOVASCULAR CARE LEADING TO INCREASED CARDIOVASCULAR MORTALITY
por: Kim, Yoo Jin, et al.
Publicado: (2022)

THE CONSEQUENCES OF THE LOCKDOWN ON CARDIOVASCULAR DISEASES
por: Aajal, Assia, et al.
Publicado: (2021)

AI ENHANCED ECG ENABLED RAPID NON-INVASIVE EXCLUSION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) INFECTION
por: Attia, Zachi Itzhak, et al.
Publicado: (2021)

CARDIOMYOPATHIC GENE MUTATIONS ALTER ACE2 EXPRESSION AND INFECTIVITY OF SARS-COV-2 IN HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES
por: Kontorovich, Amy, et al.
Publicado: (2021)

MYOCARDIAL INVOLVEMENT IN COVID-19 - DATA FROM 102 CLINICAL AND FORENSIC AUTOPSIES IN ST PETERSBURG DURING THE FIRST WAVE OF SARS-COV2 PANDEMICS
por: Platonov, Pyotr G., et al.
Publicado: (2021)

THE EFFECT OF COVID-19 ON CARDIOVASCULAR PRODUCERS
por: Annie, Frank H., et al.
Publicado: (2021)

THE IMPACT OF TELEHEALTH ON OUTCOMES IN CARDIOVASCULAR PATIENTS
por: Cioci, Anthony, et al.
Publicado: (2022)

EXAMINING DISPARITIES AND EXCESS CARDIOVASCULAR MORTALITY IN PREGNANT INDIVIDUALS BEFORE AND DURING THE COVID-19 PANDEMIC
por: Chahine, Nicole, et al.
Publicado: (2023)

PRE-EXISTING CARDIOVASCULAR DISEASE, ACUTE KIDNEY INJURY, AND CARDIOVASCULAR OUTCOMES IN HOSPITALIZED BLACKS WITH COVID-19 INFECTION
por: Egbuche, Obiora, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_efrvnpjfrs4i6un8v0bq4k63rq